DOMINOS PIZZA ENTERPRISES LIMITED UNSP ADR EACH REPR 0.5 ORD SHS
DMZPY
Precision Drilling
PDS
Constellation Brands
STZ
LIFE HEALTHCARE GROUP HOLDINGS UNSPON ADR EA REPR 4 ORD ZAR0.00
LTGHY
Ermenegildo Zegna NV
ZGN
US Stock MarketDetailed Quotes
LRMR Larimar Therapeutics
- 2.260
- -0.050-2.16%
Trading Mar 26 11:21 ET
144.70MMarket Cap-1.71P/E (TTM)
2.321High2.195Low204.16KVolume2.320Open2.310Pre Close459.43KTurnover0.65%Turnover RatioLossP/E (Static)64.03MShares11.20052wk High0.84P/B70.84MFloat Cap2.19552wk Low--Dividend TTM31.35MShs Float664.320Historical High--Div YieldTTM5.46%Amplitude1.530Historical Low2.250Avg Price1Lot Size
About Larimar Therapeutics Company
Larimar Therapeutics, Inc. Is a clinical-stage biopharmaceutical company, which engages in the research, development, and commercialization of novel therapeutics mitochondrial disorders and Friedreich's ataxia. The company was founded in 2005 and is headquartered in Bala Cynwyd, PA.
Company Profile
SymbolLRMR
Company NameLarimar Therapeutics
Listing DateJun 19, 2014
Issue Price16.00
Founded2005
CEODr. Carole Ben-Maimon, M.D.
MarketNASDAQ
Employees42
Fiscal Year Ends12-31
Address3 Bala Plaza East,Suite 506
CityBala Cynwyd
ProvincePennsylvania
CountryUnited States of America
Zip Code19004
Phone1-844-511-9056
Websitehttp://larimartx.com
Company Executives
- Name
- Position
- Salary
- Dr. Carole Ben-Maimon, M.D.
- Director, President and Chief Executive Officer
- 3.14M
- Dr. Russell G. Clayton, D.O.
- Chief Medical Officer
- --
- Dr. Gopi Shankar, F.A.A.P.,M.B.A.,PhD
- Chief Development Officer
- 1.38M
- Michael Celano
- Chief Financial Officer and Principal Accounting Officer
- 1.42M
- Joseph Truitt
- Chairman of the Board
- 114.96K
- Thomas Edward Hamilton
- Independent Director
- 77.77K
- Jonathan S. Leff
- Independent Director
- 79.96K
- Frank E. Thomas
- Independent Director
- 86.21K
- Dr. Jeffrey W. Sherman, F.A.C.P.,M.D.
- Independent Director
- 56.43K